Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'gsk 3 inhibitor 1'

Search results for: 'gsk 3 inhibitor 1'

Items 41-50 of 180

Page
per page
  1. BI-D1870
    B2227 BI-D1870
     1 Citation
    Target: p90 S6K
    Summary: P90 RSK inhibitor,ATP-competitive and cell-permeable
      insoluble in H2O; ≥19.55 mg/mL
  2. PHT-427
    A5884 PHT-427
    Summary: Akt and PDPK1 inhibitor
      insoluble in H2O; ≥20.5 mg/mL
  3. TBB
    A3861 TBB
     1 Citation
    Target: CK2
    Summary: Casein kinase-2 (CK2) inhibitor
      insoluble in H2O; ≥159.2 mg/mL
  4. NVP-BGT226
    A8488 NVP-BGT226
    Target: PI3K|mTOR
    Summary: PI3K/mTOR inhibitor,selective and novel
      insoluble in EtOH; insoluble in H2O; ≥16.28 mg/mL
  5. GDC-0084
    B7826 GDC-0084
    Summary: PI3K and mTOR inhibitor, brain-permeable
      insoluble in H2O; insoluble in EtOH; ≥2.83 mg/mL
  6. Duvelisib (IPI-145, INK1197)
    A1720 Duvelisib (IPI-145, INK1197)
    Target: PI3K
    Summary: PI3K-δ/PI3K-γ inhibitor
      ≥20.84 mg/mL
  7. WYE-687
    B1638 WYE-687
    Summary: MTOR inhibitor,ATP-competitive and selective
      insoluble in H2O; insoluble in EtOH; insoluble in DMSO
  8. MK-2206 dihydrochloride
    A3010 MK-2206 dihydrochloride
     21 Citation
    Target: Akt
    Summary: Akt1/2/3 inhibitor
      insoluble in EtOH; ≥12.01 mg/mL
  9. MHY1485
    B5853 MHY1485
     2 Citation
    Target: mTOR
    Summary: mTOR activator, autophage inhibitor
      insoluble in EtOH; insoluble in H2O; ≥19.35 mg/mL
  10. A-443654
    A3135 A-443654
    Summary: Akt inhibitor,potent and selective
      insoluble in H2O; ≥19.85 mg/mL

Items 41-50 of 180

Page
per page
Shop By
Now Shopping by
  1. Category PI3K/Akt/mTOR Signaling Remove This Item
Clear All
Shopping Options
Category
  1. Akt 29item
  2. AMPK 8item
  3. CK2 8item
  4. DNA-PK 5item
  5. eNOS 2item
  6. GSK-3 17item
  7. MELK 2item
  8. mTOR 29item
  9. PI3K 62item
  10. PI4K 1 item
  11. PDK-1 8item
  12. PIKfyve 1 item
  13. PKB 1 item
  14. S6 Kinase 8item
Specificity
  1. Selective 63item
Reversibility
  1. Reversible 4item
  2. Irreversible 1 item
Target
  1. Cyclin-Dependent Kinases 2item
  2. Histone Deacetylases (HDACs) 1 item
  3. Akt 13item
  4. PI3K 36item
  5. mTOR 22item
  6. GSK-3 10item
  7. Eph Receptors 1 item
  8. VEGFR 1 item
  9. PDGFR 1 item
  10. Bcr-Abl 1 item
  11. Pim 1 item
  12. Ribosomal s6 kinases (RSK) 1 item
  13. Src 1 item
  14. DNA-PK 8item
  15. AMPK 3item
  16. S6 kinases 1 item
  17. ERK 1 item
  18. PKC 2item
  19. PKG 1 item
  20. PKA 3item
  21. MELK 1 item
  22. NUAK1 1 item
  23. NUAK2 1 item
  24. RSK 1 item
  25. ATM/ATR 2item
  26. CK2 3item
  27. HIPK2 1 item
  28. HIPK3 1 item
  29. P110 1 item
  30. Hck 1 item
  31. p70 rsk 3item
  32. PDK-1 1 item
  33. Prk 1 item
  34. NUAK 1 item
  35. NOS 1 item
  36. PIM1 kinase 1 item
  37. phospholipase A2 1 item
  38. ATM 1 item
  39. PIKfyve 1 item
  40. p90 S6K 1 item
Reported Experiments
  1. Animal Experiments 80item
  2. Cell Experiments 61item
Related Disease
  1. Acute Myeloid Leukemia 1 item
  2. Adrenocortical Carcinoma 1 item
  3. Bladder Cancer 1 item
  4. Bladder Carcinoma 1 item
  5. Breast Cancer 14item
  6. Cancer 51item
  7. Cervical Cancer 1 item
  8. Cholangiocarcinoma 1 item
  9. Chronic Lymphocytic Leukemia 1 item
  10. Colon Cancer 3item
  11. Colon Carcinoma 1 item
  12. Colorectal Cancer 2item
  13. Diabetes 1 item
  14. Glioblastoma 5item
  15. Glioma 5item
  16. Hepatocellular Carcinoma 1 item
  17. Leukemia 1 item
  18. Lung Cancer 6item
  19. Melanoma 2item
  20. Neuroblastoma 2item
  21. Non-small Cell Lung Cancer 1 item
  22. Ovarian Cancer 4item
  23. Pancreatic Cancer 6item
  24. Prostate Cancer 5item
  25. Renal Cancer 1 item
  26. Rheumatoid Arthritis 1 item
  27. Type 2 Diabetes 1 item